NCT07188272

Brief Summary

Cardiovascular disease (CVD) is one of the leading causes of mortality worldwide and a major risk factor for morbidity worldwide . It is necessary to reduce the incidence and risk factors of CVD, as physical activity is known to reduce mortality from CVD. Arterial stiffness and hypertension are closely related in pathophysiology. Chronic high blood pressure (BP) can lead to arterial wall damage by mechanical stress, endothelial dysfunction, increased inflammation, oxidative stress, and renin-angiotensin-aldosterone system (RAAS) activation. HIIT has been shown to be equally or even better at stimulating health benefits than moderate-intensity continuous training (MICT) and is considered a time-saving aerobic exercise for reducing arterial stiffness in HTN patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 23, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2025

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

September 15, 2025

Last Update Submit

April 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pulse Wave Velocity

    normal level 60-100 per minutes

    each week

Study Arms (2)

DASH diet group

EXPERIMENTAL

22 patients will receive hypotensive drugs and High Intensity Interval Training ( HIIT) combined with DASH diet.

Dietary Supplement: DASH diet

Comparator group

ACTIVE COMPARATOR

22 patients will receive hypotensive drugs and High Intensity Interval Training ( HIIT)

Procedure: High Intensity Interval Training

Interventions

DASH dietDIETARY_SUPPLEMENT

Eating vegetables, fruits, and whole grains Including fat-free or low-fat dairy products, fish, poultry, beans, nuts, and vegetable oils Limiting foods that are high in saturated fat, such as fatty meats, full-fat dairy products, and tropical oils such as coconut, palm kernel, and palm oils Limiting sugar-sweetened beverages and sweets

DASH diet group

High Intensity Interval Training

Comparator group

Eligibility Criteria

Age35 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Their age\< 35 up to 50 years old
  • Both sexes.
  • Controlled HTN ( stage 1,B.P 140-159 mmhg / 90-99 mmhg and stage 2, B.P 160-179 mmhg-100-109 mmhg )
  • Hemodynamic stable. Able to provide informed consent

You may not qualify if:

  • Uncontrolled hypertension.
  • Severe HTN \<180/110 mmhg
  • Renal dysfunction
  • Unstable cardiac conditions
  • Severe pulmonary disease that limit exercise
  • Impaired cognition
  • Musculoskeletal problems that made it difficult to do exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Waleed Mohamed Abdelmohsen Abdelsalalm

Minya, Egypt

Location

MeSH Terms

Conditions

Hypertension

Interventions

Dietary Approaches To Stop HypertensionHigh-Intensity Interval Training

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2025

First Posted

September 23, 2025

Study Start

July 10, 2025

Primary Completion

December 10, 2025

Study Completion

January 1, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Locations